SCHEMBL9918953

SCHEMBL9918953

C=CCOc1ccc(N=C=O)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
TRPA1 O75762 1/20 0.45
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 3/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 2/20 0.38
GAA P10253 2/20 0.38
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PDE4B Q07343 3/20 0.36
PDE4A P27815 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918951 0.88 CYP3A4 (0.49) CYP3A4TRPA1ALDH1A1KDM4EHPGD
SCHEMBL10980256 0.81 CYP3A4 (0.42) CYP3A4TRPA1ALDH1A1KDM4EHPGD
SCHEMBL9528156 0.79 MAPK1 (0.51) CYP3A4TRPA1ALDH1A1HPGDTSHR
SCHEMBL11686348 0.78 CYP3A4 (0.46) CYP3A4TRPA1ALDH1A1KDM4EHPGD
SCHEMBL9918952 0.77 HPGD (0.39) CYP3A4TRPA1ALDH1A1KDM4EHPGD
SCHEMBL9918935 0.75 HPGD (0.35) ALDH1A1KDM4EHPGDMAPTTSHR
SCHEMBL2454654 0.74 CA12 (0.49) CYP3A4ALDH1A1HPGDMAPTTSHR
SCHEMBL8161827 0.74 SMN1; SMN2 (0.45) ALDH1A1KDM4EHPGDMAPTTSHR
SCHEMBL30401497 0.74 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDMAPTTSHR
SCHEMBL9918941 0.73 ALDH1A1 (0.43) CYP3A4TRPA1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
WO-2011022457-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS INC. (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF CUTA, PUF60, PAM CYP3A4 2144/4885TRPA1 718/4885ALDH1A1 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.